Efficacy and Safety of Long-Term Imatinib Therapy

Jun 3, 2015 - Conclusions: Long-term treatment with imatinib may improve the functional class and quality of life. ..... characteristic signs on chest...

0 downloads 0 Views 548KB Size

Recommend Documents

May 19, 2011 - ... burden with a clinically manageable safety profile in patients with b-thalassaemia and ...... Schwartz, G.J., Brion, L.P. & Spitzer, A. (1987) The.

Apr 25, 2013 - 86Б9% at 36 months), reflecting inhibition of chronic haemolysis. TEs decreased by 81Б8%, with 96Б4% of patients remaining free of TEs. Patients also showed a ..... talizations for a disc prolapse, pneumonia and renal failure, the p

This phase 2 pilot study was conducted to determine the efficacy and safety of imatinib mesylate in patients with c-kit– positive acute myeloid leukemia (AML) refractory to or not eligible for chemo- therapy. Twenty-one patients were en- rolled and

Jul 13, 2005 - arthropathy: clinicopathological studies on articular lesions caused by oxolinic and pipemidic acids. Toxicol Appl Pharmacol 1979; 51:177–87.

Imatinib has substantially changed the clinical management and improved the prognosis of CML and Philadelphia chromosome-positive acute lymphocytic leukemia (Ph+ ALL). Here, we review the pharmacology, mode of action, and pharmacokinetics of imatinib

hypokalemia and hypernatremia, which was effectively treated before ECT administration. Standard laboratory test revealed also elevated fastening glucose ...

Feb 20, 2003 - Jorge Cortes, Patricia Ault, Charles Koller, Deborah Thomas, Alessandra Ferrajoli, William Wierda, hypereosinophilic syndrome. Efficacy of imatinib mesylate in the treatment of idiopathic http://bloodjournal.hematologylibrary.org/conte

Abstract. The number of cancer patients undergoing dialysis has been increasing, and the number of these patients on chemotherapy is also increasing. Imatinib is an effective and safe therapy for KIT-positive gastrointestinal stromal tumors (GIST), b

Aug 19, 2013 - Chen Yao8, Zhi-Gang Zhao9, Ru-Ya Zhang10, Xiang-Ling Wang10, Lei Wang10 and VISION Study Group. Abstract. Background ...... 2002, 25:869–875. 23. Richter B, Bandeira-Echtler E, Bergerhoff K, Lerch CL: Dipeptidyl peptidase-4. (DPP-4)

(AIRC; MFAG 11817 to T. Negri) and by Fondazione Italiana Ricerca sul Cancro. (FIRC) with a fellowship for M. Tazzari. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereb

Treatment-emergent AEs occurring more frequently for naloxegol vs. UC were abdominal ... to diarrhoea and nine patients owing to abdominal pain. Pain scores and .... perspiration, tremor, mydriasis, piloerection and restless- ness on a scale ...

Jul 27, 2017 - dexamethasone (ixazomib-Rd), was approved in 2015 by the US Food ... by a blinded independent review committee (IRC). ..... 58/170 (34).

Biological treatment, in Crohn's disease, stays at the top of the pyramid treatment .... tory infection after the IV dose, treated with Augmentin, conjunctivitis after VIII ...

Keywords: Pemetrexed, maintenance, lung cancer ... icity profile and clinical efficacy such as pemetrexed ..... either 4 cycles of carboplatin/pemetrexed/bevaci-.

Jul 21, 2014 - Fosfomycin plus imipenem was an effective and safe combination when used as .... Initial antibiotic treatment was considered appropriate if the.

Nov 18, 2015 - Background: Extracorporeal shock wave therapy (ESWT) is an .... within a guiding tube that strikes a metal applicator placed on the skin.

Oct 25, 2013 - anti-angiogenic drug is aflibercept (VEGF-trap eye, Eylea™,. Regeneron ... decision between the different therapeutic options and to calculate the ..... Russo et al. compared intravitreal bevacizumab 1.25 mg after PRN ...

Key Words: cholesterol .... In girls, -human chorionic gonadotropin was ... 1.220.31. TGs, mmol/L. 0.88 (0.47–3.15). 1.02 (0.44–3.68). ApoA-I, mg/dL ..... Values are meanSD, except for testosterone, estradiol, menstrual cycle, and DHEAS, which ar

Apr 20, 2016 - graphic cyst decompression with large fenestration of cyst and endo- .... liver enzym es. Amy lase declined to. 160. IU after cyst drained. US:.

Reducing the epoetin dose in patients may attenuate several potentially untoward ..... maintenance iron therapy that is generated by reducing epoetin. J Am Soc ...

have been effectively used for more than 20 years for the treatment of iron overload in TM and TI patients, causing a significant reduction in morbidity and ...

Glucocorticoids IgA nephropathy. Abstract. Background: Published reports examining the efficacy and safety of glucocorticoids for preserving renal function in im ...

Nov 15, 2016 - Methods. Three databases of PubMed, EMBASE and Cochrane Library were searched for related studies published in English up to December, 2015. Randomized controlled trials (RCTs) of corticosteroids in hospitalized adults with severe CAP

group achieved absolute neutrophil count (ANC) and platelet count responses more ...... from 21- to 23.5-year cryopreserved cord blood. Blood 117: 4773-4777 ...